Skip to main content
Equibles

Truvestments Capital LLC

Position in AKTX — Akari Therapeutics Plc

CIK 1750405 SARASOTA, FL
Back to AKTX Full portfolio

Position in AKTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$10
+$5 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 9 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Truvestments Capital LLC holds $2,305,139 across 79 Biotechnology names. AKTX ranks #76 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 7,833 $426,193
2 TWST
Twist Bioscience Corp
 1,773 $182,406
3 CRVS
Corvus Pharmaceuticals, Inc.
 10,195 $152,313
4 PTGX
Protagonist Therapeutics, Inc
 1,156 $141,702
5 ROIV
Roivant Sciences Ltd.
 3,788 $134,057
6 CTMX
CytomX Therapeutics, Inc.
 27,988 $104,955
7 TGTX
Tg Therapeutics, Inc.
 1,764 $96,914
8 RIGL
Rigel Pharmaceuticals Inc
 2,387 $93,379

All Filings in AKTX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10 1
2026-03-31 $5 1
2025-12-31 $14 50
2025-09-30 $50 50
2025-06-30 $58 50
2025-03-31 $62 50
2024-12-31 $61 50
2024-09-30 $147 50
2024-03-31 $93 50
2023-12-31 $156 50
2023-09-30 $197 50
2023-06-30 $170 1,005
2023-03-31 $182 1,005
2022-12-31 $472 1,005
2022-09-30 $1,021 1,621
2022-06-30 $1,621 1,621
2021-12-31 $2,431 1,621
2021-09-30 $2,642 1,621
2021-06-30 $2,804 1,621
2021-03-31 $4,279 1,621
2020-12-31 $3,968 2,145
2020-06-30 $4,676 2,145